nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadobenate Dimeglumine—ALB—epilepsy syndrome	0.263	1	CbGaD
Gadobenate Dimeglumine—ALB—Oxcarbazepine—epilepsy syndrome	0.0988	0.205	CbGbCtD
Gadobenate Dimeglumine—ALB—Fosphenytoin—epilepsy syndrome	0.0863	0.179	CbGbCtD
Gadobenate Dimeglumine—ALB—Clonazepam—epilepsy syndrome	0.0781	0.162	CbGbCtD
Gadobenate Dimeglumine—ALB—Rufinamide—epilepsy syndrome	0.0637	0.132	CbGbCtD
Gadobenate Dimeglumine—ALB—Phenytoin—epilepsy syndrome	0.0556	0.116	CbGbCtD
Gadobenate Dimeglumine—ALB—Propofol—epilepsy syndrome	0.0519	0.108	CbGbCtD
Gadobenate Dimeglumine—ALB—Diazepam—epilepsy syndrome	0.047	0.0976	CbGbCtD
Gadobenate Dimeglumine—ALB—Transport of organic anions—SLCO1A2—epilepsy syndrome	0.00111	0.0776	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Recycling of bile acids and salts—SLCO1A2—epilepsy syndrome	0.000825	0.0575	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transport of vitamins, nucleosides, and related molecules—SLC35A3—epilepsy syndrome	0.000545	0.038	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transport of vitamins, nucleosides, and related molecules—SLC35A2—epilepsy syndrome	0.000545	0.038	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Bile acid and bile salt metabolism—SLCO1A2—epilepsy syndrome	0.000431	0.0301	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transport of vitamins, nucleosides, and related molecules—SLCO1A2—epilepsy syndrome	0.000413	0.0288	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Folate Metabolism—FOLR1—epilepsy syndrome	0.000393	0.0274	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Bile acid and bile salt metabolism—HSD17B4—epilepsy syndrome	0.00038	0.0265	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—SEPW1—epilepsy syndrome	0.000367	0.0256	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transport of vitamins, nucleosides, and related molecules—APOD—epilepsy syndrome	0.000321	0.0224	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transport of organic anions—AVP—epilepsy syndrome	0.000321	0.0223	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet degranulation—LAMP2—epilepsy syndrome	0.000275	0.0191	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Response to elevated platelet cytosolic Ca2+—LAMP2—epilepsy syndrome	0.000262	0.0182	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—PNPO—epilepsy syndrome	0.000255	0.0177	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—FOXA2 and FOXA3 transcription factor networks—KCNJ11—epilepsy syndrome	0.000201	0.014	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—HDL-mediated lipid transport—APOE—epilepsy syndrome	0.000193	0.0135	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet degranulation—FLNA—epilepsy syndrome	0.000138	0.00961	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—TXNRD1—epilepsy syndrome	0.000132	0.00917	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Response to elevated platelet cytosolic Ca2+—FLNA—epilepsy syndrome	0.000131	0.00916	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—LAMP2—epilepsy syndrome	0.000122	0.00849	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Vitamin B12 Metabolism—PLAT—epilepsy syndrome	0.000121	0.00842	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transport of vitamins, nucleosides, and related molecules—AVP—epilepsy syndrome	0.000119	0.00828	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—SLC-mediated transmembrane transport—SLC35A3—epilepsy syndrome	0.000117	0.00815	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—SLC-mediated transmembrane transport—SLC12A5—epilepsy syndrome	0.000117	0.00815	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—SLC-mediated transmembrane transport—SLC35A2—epilepsy syndrome	0.000117	0.00815	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Lipoprotein metabolism—APOE—epilepsy syndrome	0.000111	0.00774	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet degranulation—PPIA—epilepsy syndrome	0.000109	0.00756	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—SLC-mediated transmembrane transport—SLC4A10—epilepsy syndrome	0.000107	0.00746	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Response to elevated platelet cytosolic Ca2+—PPIA—epilepsy syndrome	0.000103	0.0072	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Folate Metabolism—PLAT—epilepsy syndrome	9.83e-05	0.00685	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—FOXA2 and FOXA3 transcription factor networks—NR3C1—epilepsy syndrome	9.2e-05	0.00641	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—SLC-mediated transmembrane transport—SLC9A6—epilepsy syndrome	8.87e-05	0.00618	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—SLC-mediated transmembrane transport—SLCO1A2—epilepsy syndrome	8.87e-05	0.00618	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—SLC-mediated transmembrane transport—SLC8A2—epilepsy syndrome	8.87e-05	0.00618	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—epilepsy syndrome	8.65e-05	0.00603	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—SLC-mediated transmembrane transport—SLC8A3—epilepsy syndrome	8.46e-05	0.00589	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—PLAT—epilepsy syndrome	7.81e-05	0.00544	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—DOCK7—epilepsy syndrome	7.71e-05	0.00537	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Folate Metabolism—CAT—epilepsy syndrome	7.61e-05	0.0053	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Vitamin B12 Metabolism—CRP—epilepsy syndrome	7.43e-05	0.00517	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Lipid and lipoprotein metabolism—APOE—epilepsy syndrome	7.38e-05	0.00514	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Vitamin B12 Metabolism—APOE—epilepsy syndrome	7.27e-05	0.00506	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—SLC-mediated transmembrane transport—APOD—epilepsy syndrome	6.9e-05	0.00481	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Folate Metabolism—GPX1—epilepsy syndrome	6.88e-05	0.0048	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—SLC-mediated transmembrane transport—SLC1A1—epilepsy syndrome	6.72e-05	0.00468	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—SLC-mediated transmembrane transport—SLC12A2—epilepsy syndrome	6.72e-05	0.00468	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—CLCN6—epilepsy syndrome	6.67e-05	0.00465	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—CLCN2—epilepsy syndrome	6.67e-05	0.00465	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—LAMP2—epilepsy syndrome	6.28e-05	0.00438	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—CERS1—epilepsy syndrome	6.25e-05	0.00436	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—FAR1—epilepsy syndrome	6.25e-05	0.00436	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—SLC-mediated transmembrane transport—SLC17A7—epilepsy syndrome	6.15e-05	0.00428	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—FLNA—epilepsy syndrome	6.12e-05	0.00426	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Vitamin B12 Metabolism—CCL2—epilepsy syndrome	6.11e-05	0.00426	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—CAT—epilepsy syndrome	6.05e-05	0.00421	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Folate Metabolism—CRP—epilepsy syndrome	6.04e-05	0.00421	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—SLC35A3—epilepsy syndrome	5.95e-05	0.00414	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—SLC35A2—epilepsy syndrome	5.95e-05	0.00414	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—SLC12A5—epilepsy syndrome	5.95e-05	0.00414	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—SLC-mediated transmembrane transport—SLC1A2—epilepsy syndrome	5.71e-05	0.00398	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—GPX1—epilepsy syndrome	5.47e-05	0.00381	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—SLC4A10—epilepsy syndrome	5.44e-05	0.00379	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—SLC8A2—epilepsy syndrome	5.21e-05	0.00363	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Vitamin B12 Metabolism—RELA—epilepsy syndrome	5.13e-05	0.00357	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—SLC-mediated transmembrane transport—SLC8A1—epilepsy syndrome	5.03e-05	0.00351	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Folate Metabolism—CCL2—epilepsy syndrome	4.97e-05	0.00346	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—SLC8A3—epilepsy syndrome	4.97e-05	0.00346	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—SLC-mediated transmembrane transport—SLC1A3—epilepsy syndrome	4.86e-05	0.00339	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—PPIA—epilepsy syndrome	4.81e-05	0.00335	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—CRP—epilepsy syndrome	4.8e-05	0.00334	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—COX3—epilepsy syndrome	4.75e-05	0.00331	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	4.74e-05	0.0033	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Vitamin B12 Metabolism—IL1B—epilepsy syndrome	4.63e-05	0.00323	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Response to elevated platelet cytosolic Ca2+—PRKCB—epilepsy syndrome	4.55e-05	0.00317	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	4.51e-05	0.00314	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	4.51e-05	0.00314	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	4.51e-05	0.00314	CbGpPWpGaD
Gadobenate Dimeglumine—Hyperhidrosis—Valproic Acid—epilepsy syndrome	4.35e-05	0.00018	CcSEcCtD
Gadobenate Dimeglumine—Cough—Pregabalin—epilepsy syndrome	4.35e-05	0.00018	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Phenytoin—epilepsy syndrome	4.34e-05	0.00018	CcSEcCtD
Gadobenate Dimeglumine—Connective tissue disorder—Topiramate—epilepsy syndrome	4.34e-05	0.00018	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Levetiracetam—epilepsy syndrome	4.34e-05	0.00018	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	4.34e-05	0.00302	CbGpPWpGaD
Gadobenate Dimeglumine—Rash—Vigabatrin—epilepsy syndrome	4.33e-05	0.000179	CcSEcCtD
Gadobenate Dimeglumine—ALB—SLC-mediated transmembrane transport—SLC6A1—epilepsy syndrome	4.33e-05	0.00302	CbGpPWpGaD
Gadobenate Dimeglumine—Dizziness—Felbamate—epilepsy syndrome	4.33e-05	0.000179	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Vigabatrin—epilepsy syndrome	4.33e-05	0.000179	CcSEcCtD
Gadobenate Dimeglumine—Urethral disorder—Topiramate—epilepsy syndrome	4.33e-05	0.000179	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Oxcarbazepine—epilepsy syndrome	4.32e-05	0.000179	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Carbamazepine—epilepsy syndrome	4.31e-05	0.000179	CcSEcCtD
Gadobenate Dimeglumine—Headache—Vigabatrin—epilepsy syndrome	4.3e-05	0.000178	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Pregabalin—epilepsy syndrome	4.3e-05	0.000178	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Diazepam—epilepsy syndrome	4.3e-05	0.000178	CcSEcCtD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	4.3e-05	0.003	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	4.3e-05	0.003	CbGpPWpGaD
Gadobenate Dimeglumine—Tremor—Gabapentin—epilepsy syndrome	4.28e-05	0.000177	CcSEcCtD
Gadobenate Dimeglumine—Rash—Diazepam—epilepsy syndrome	4.27e-05	0.000177	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Diazepam—epilepsy syndrome	4.26e-05	0.000177	CcSEcCtD
Gadobenate Dimeglumine—Visual impairment—Topiramate—epilepsy syndrome	4.25e-05	0.000176	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Pregabalin—epilepsy syndrome	4.24e-05	0.000176	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Pregabalin—epilepsy syndrome	4.24e-05	0.000176	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Pregabalin—epilepsy syndrome	4.24e-05	0.000176	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Gabapentin—epilepsy syndrome	4.24e-05	0.000176	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Zonisamide—epilepsy syndrome	4.24e-05	0.000176	CcSEcCtD
Gadobenate Dimeglumine—Headache—Diazepam—epilepsy syndrome	4.24e-05	0.000176	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Pregabalin—epilepsy syndrome	4.23e-05	0.000175	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Clonazepam—epilepsy syndrome	4.23e-05	0.000175	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Gabapentin—epilepsy syndrome	4.22e-05	0.000175	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	4.21e-05	0.000174	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Valproic Acid—epilepsy syndrome	4.2e-05	0.000174	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Carbamazepine—epilepsy syndrome	4.2e-05	0.000174	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Phenytoin—epilepsy syndrome	4.2e-05	0.000174	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Pregabalin—epilepsy syndrome	4.19e-05	0.000174	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Fosphenytoin—epilepsy syndrome	4.19e-05	0.000173	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Oxcarbazepine—epilepsy syndrome	4.18e-05	0.000173	CcSEcCtD
Gadobenate Dimeglumine—Angioedema—Gabapentin—epilepsy syndrome	4.17e-05	0.000173	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	4.17e-05	0.00291	CbGpPWpGaD
Gadobenate Dimeglumine—Hypersensitivity—Lamotrigine—epilepsy syndrome	4.17e-05	0.000173	CcSEcCtD
Gadobenate Dimeglumine—ALB—Folate Metabolism—RELA—epilepsy syndrome	4.17e-05	0.00291	CbGpPWpGaD
Gadobenate Dimeglumine—Vomiting—Felbamate—epilepsy syndrome	4.16e-05	0.000172	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Pregabalin—epilepsy syndrome	4.15e-05	0.000172	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Carbamazepine—epilepsy syndrome	4.14e-05	0.000172	CcSEcCtD
Gadobenate Dimeglumine—Rash—Felbamate—epilepsy syndrome	4.13e-05	0.000171	CcSEcCtD
Gadobenate Dimeglumine—Eye disorder—Topiramate—epilepsy syndrome	4.13e-05	0.000171	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Felbamate—epilepsy syndrome	4.12e-05	0.000171	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Gabapentin—epilepsy syndrome	4.12e-05	0.000171	CcSEcCtD
Gadobenate Dimeglumine—Tinnitus—Topiramate—epilepsy syndrome	4.12e-05	0.000171	CcSEcCtD
Gadobenate Dimeglumine—Headache—Felbamate—epilepsy syndrome	4.1e-05	0.00017	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Pregabalin—epilepsy syndrome	4.1e-05	0.00017	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	4.1e-05	0.00017	CcSEcCtD
Gadobenate Dimeglumine—Flushing—Topiramate—epilepsy syndrome	4.1e-05	0.00017	CcSEcCtD
Gadobenate Dimeglumine—Cardiac disorder—Topiramate—epilepsy syndrome	4.1e-05	0.00017	CcSEcCtD
Gadobenate Dimeglumine—Syncope—Gabapentin—epilepsy syndrome	4.1e-05	0.00017	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Gabapentin—epilepsy syndrome	4.09e-05	0.000169	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Clonazepam—epilepsy syndrome	4.08e-05	0.000169	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Vigabatrin—epilepsy syndrome	4.08e-05	0.000169	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Zonisamide—epilepsy syndrome	4.07e-05	0.000169	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Pregabalin—epilepsy syndrome	4.07e-05	0.000168	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Lamotrigine—epilepsy syndrome	4.06e-05	0.000168	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Phenytoin—epilepsy syndrome	4.06e-05	0.000168	CcSEcCtD
Gadobenate Dimeglumine—Rash—Zonisamide—epilepsy syndrome	4.04e-05	0.000167	CcSEcCtD
Gadobenate Dimeglumine—Infection—Pregabalin—epilepsy syndrome	4.04e-05	0.000167	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Valproic Acid—epilepsy syndrome	4.04e-05	0.000167	CcSEcCtD
Gadobenate Dimeglumine—Palpitations—Gabapentin—epilepsy syndrome	4.04e-05	0.000167	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Zonisamide—epilepsy syndrome	4.04e-05	0.000167	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Oxcarbazepine—epilepsy syndrome	4.04e-05	0.000167	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Diazepam—epilepsy syndrome	4.02e-05	0.000166	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Gabapentin—epilepsy syndrome	4.02e-05	0.000166	CcSEcCtD
Gadobenate Dimeglumine—Headache—Zonisamide—epilepsy syndrome	4.01e-05	0.000166	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Valproic Acid—epilepsy syndrome	4.01e-05	0.000166	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Carbamazepine—epilepsy syndrome	4.01e-05	0.000166	CcSEcCtD
Gadobenate Dimeglumine—Angiopathy—Topiramate—epilepsy syndrome	4.01e-05	0.000166	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Lamotrigine—epilepsy syndrome	4e-05	0.000166	CcSEcCtD
Gadobenate Dimeglumine—Shock—Pregabalin—epilepsy syndrome	4e-05	0.000166	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Valproic Acid—epilepsy syndrome	4e-05	0.000166	CcSEcCtD
Gadobenate Dimeglumine—Immune system disorder—Topiramate—epilepsy syndrome	3.99e-05	0.000165	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Pregabalin—epilepsy syndrome	3.99e-05	0.000165	CcSEcCtD
Gadobenate Dimeglumine—Cough—Gabapentin—epilepsy syndrome	3.99e-05	0.000165	CcSEcCtD
Gadobenate Dimeglumine—Mediastinal disorder—Topiramate—epilepsy syndrome	3.98e-05	0.000165	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Pregabalin—epilepsy syndrome	3.97e-05	0.000164	CcSEcCtD
Gadobenate Dimeglumine—Chills—Topiramate—epilepsy syndrome	3.96e-05	0.000164	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Valproic Acid—epilepsy syndrome	3.96e-05	0.000164	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Pregabalin—epilepsy syndrome	3.95e-05	0.000164	CcSEcCtD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—CCL2—epilepsy syndrome	3.95e-05	0.00275	CbGpPWpGaD
Gadobenate Dimeglumine—Hypertension—Gabapentin—epilepsy syndrome	3.94e-05	0.000163	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Pregabalin—epilepsy syndrome	3.93e-05	0.000163	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Clonazepam—epilepsy syndrome	3.93e-05	0.000163	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Phenytoin—epilepsy syndrome	3.9e-05	0.000162	CcSEcCtD
Gadobenate Dimeglumine—Rash—Clonazepam—epilepsy syndrome	3.89e-05	0.000161	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Clonazepam—epilepsy syndrome	3.89e-05	0.000161	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Gabapentin—epilepsy syndrome	3.89e-05	0.000161	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Gabapentin—epilepsy syndrome	3.89e-05	0.000161	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Gabapentin—epilepsy syndrome	3.89e-05	0.000161	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Felbamate—epilepsy syndrome	3.89e-05	0.000161	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	3.88e-05	0.000161	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Oxcarbazepine—epilepsy syndrome	3.88e-05	0.000161	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Valproic Acid—epilepsy syndrome	3.88e-05	0.000161	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Gabapentin—epilepsy syndrome	3.88e-05	0.000161	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Carbamazepine—epilepsy syndrome	3.87e-05	0.00016	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Lamotrigine—epilepsy syndrome	3.87e-05	0.00016	CcSEcCtD
Gadobenate Dimeglumine—Headache—Clonazepam—epilepsy syndrome	3.87e-05	0.00016	CcSEcCtD
Gadobenate Dimeglumine—Rash—Phenytoin—epilepsy syndrome	3.87e-05	0.00016	CcSEcCtD
Gadobenate Dimeglumine—Mental disorder—Topiramate—epilepsy syndrome	3.87e-05	0.00016	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Phenytoin—epilepsy syndrome	3.86e-05	0.00016	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	3.86e-05	0.00016	CcSEcCtD
Gadobenate Dimeglumine—Rash—Oxcarbazepine—epilepsy syndrome	3.85e-05	0.000159	CcSEcCtD
Gadobenate Dimeglumine—Pain—Valproic Acid—epilepsy syndrome	3.85e-05	0.000159	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Valproic Acid—epilepsy syndrome	3.85e-05	0.000159	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Oxcarbazepine—epilepsy syndrome	3.84e-05	0.000159	CcSEcCtD
Gadobenate Dimeglumine—Headache—Phenytoin—epilepsy syndrome	3.84e-05	0.000159	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Topiramate—epilepsy syndrome	3.84e-05	0.000159	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Topiramate—epilepsy syndrome	3.84e-05	0.000159	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Gabapentin—epilepsy syndrome	3.84e-05	0.000159	CcSEcCtD
Gadobenate Dimeglumine—Headache—Oxcarbazepine—epilepsy syndrome	3.82e-05	0.000158	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Zonisamide—epilepsy syndrome	3.81e-05	0.000158	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Gabapentin—epilepsy syndrome	3.8e-05	0.000158	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Pregabalin—epilepsy syndrome	3.8e-05	0.000157	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	3.79e-05	0.00264	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Folate Metabolism—IL1B—epilepsy syndrome	3.77e-05	0.00263	CbGpPWpGaD
Gadobenate Dimeglumine—Dysgeusia—Topiramate—epilepsy syndrome	3.76e-05	0.000156	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Gabapentin—epilepsy syndrome	3.76e-05	0.000156	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—ADRA2A—epilepsy syndrome	3.75e-05	0.00262	CbGpPWpGaD
Gadobenate Dimeglumine—Dizziness—Lamotrigine—epilepsy syndrome	3.74e-05	0.000155	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Gabapentin—epilepsy syndrome	3.73e-05	0.000154	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Carbamazepine—epilepsy syndrome	3.72e-05	0.000154	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Topiramate—epilepsy syndrome	3.72e-05	0.000154	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Valproic Acid—epilepsy syndrome	3.71e-05	0.000154	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	3.7e-05	0.000153	CcSEcCtD
Gadobenate Dimeglumine—Infection—Gabapentin—epilepsy syndrome	3.7e-05	0.000153	CcSEcCtD
Gadobenate Dimeglumine—Muscle spasms—Topiramate—epilepsy syndrome	3.7e-05	0.000153	CcSEcCtD
Gadobenate Dimeglumine—Rash—Carbamazepine—epilepsy syndrome	3.69e-05	0.000153	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Carbamazepine—epilepsy syndrome	3.69e-05	0.000153	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	3.68e-05	0.000152	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism—CA13—epilepsy syndrome	3.68e-05	0.00256	CbGpPWpGaD
Gadobenate Dimeglumine—Nausea—Clonazepam—epilepsy syndrome	3.67e-05	0.000152	CcSEcCtD
Gadobenate Dimeglumine—Headache—Carbamazepine—epilepsy syndrome	3.67e-05	0.000152	CcSEcCtD
Gadobenate Dimeglumine—Shock—Gabapentin—epilepsy syndrome	3.67e-05	0.000152	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Gabapentin—epilepsy syndrome	3.66e-05	0.000151	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Pregabalin—epilepsy syndrome	3.65e-05	0.000151	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Phenytoin—epilepsy syndrome	3.64e-05	0.000151	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Gabapentin—epilepsy syndrome	3.64e-05	0.000151	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Pregabalin—epilepsy syndrome	3.63e-05	0.00015	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Oxcarbazepine—epilepsy syndrome	3.62e-05	0.00015	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Gabapentin—epilepsy syndrome	3.62e-05	0.00015	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Pregabalin—epilepsy syndrome	3.61e-05	0.00015	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Gabapentin—epilepsy syndrome	3.6e-05	0.000149	CcSEcCtD
Gadobenate Dimeglumine—Tremor—Topiramate—epilepsy syndrome	3.6e-05	0.000149	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Lamotrigine—epilepsy syndrome	3.6e-05	0.000149	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Valproic Acid—epilepsy syndrome	3.57e-05	0.000148	CcSEcCtD
Gadobenate Dimeglumine—Rash—Lamotrigine—epilepsy syndrome	3.57e-05	0.000148	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Topiramate—epilepsy syndrome	3.57e-05	0.000148	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Lamotrigine—epilepsy syndrome	3.57e-05	0.000148	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Valproic Acid—epilepsy syndrome	3.56e-05	0.000147	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Valproic Acid—epilepsy syndrome	3.56e-05	0.000147	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Topiramate—epilepsy syndrome	3.55e-05	0.000147	CcSEcCtD
Gadobenate Dimeglumine—Headache—Lamotrigine—epilepsy syndrome	3.55e-05	0.000147	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	3.51e-05	0.000145	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Pregabalin—epilepsy syndrome	3.51e-05	0.000145	CcSEcCtD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—APOD—epilepsy syndrome	3.5e-05	0.00244	CbGpPWpGaD
Gadobenate Dimeglumine—Hypotension—Gabapentin—epilepsy syndrome	3.48e-05	0.000144	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Carbamazepine—epilepsy syndrome	3.48e-05	0.000144	CcSEcCtD
Gadobenate Dimeglumine—Pain—Pregabalin—epilepsy syndrome	3.48e-05	0.000144	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Pregabalin—epilepsy syndrome	3.48e-05	0.000144	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Topiramate—epilepsy syndrome	3.47e-05	0.000144	CcSEcCtD
Gadobenate Dimeglumine—Syncope—Topiramate—epilepsy syndrome	3.45e-05	0.000143	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Topiramate—epilepsy syndrome	3.44e-05	0.000143	CcSEcCtD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	3.42e-05	0.00238	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	3.42e-05	0.00238	CbGpPWpGaD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	3.4e-05	0.000141	CcSEcCtD
Gadobenate Dimeglumine—Palpitations—Topiramate—epilepsy syndrome	3.4e-05	0.000141	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Topiramate—epilepsy syndrome	3.38e-05	0.00014	CcSEcCtD
Gadobenate Dimeglumine—ALB—Vitamin B12 Metabolism—TNF—epilepsy syndrome	3.36e-05	0.00234	CbGpPWpGaD
Gadobenate Dimeglumine—Nausea—Lamotrigine—epilepsy syndrome	3.36e-05	0.000139	CcSEcCtD
Gadobenate Dimeglumine—ALB—Hemostasis—TEK—epilepsy syndrome	3.35e-05	0.00234	CbGpPWpGaD
Gadobenate Dimeglumine—Cough—Topiramate—epilepsy syndrome	3.35e-05	0.000139	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Pregabalin—epilepsy syndrome	3.35e-05	0.000139	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Gabapentin—epilepsy syndrome	3.35e-05	0.000139	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Pregabalin—epilepsy syndrome	3.32e-05	0.000138	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Gabapentin—epilepsy syndrome	3.32e-05	0.000138	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Topiramate—epilepsy syndrome	3.32e-05	0.000137	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Gabapentin—epilepsy syndrome	3.31e-05	0.000137	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Valproic Acid—epilepsy syndrome	3.31e-05	0.000137	CcSEcCtD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—RELA—epilepsy syndrome	3.31e-05	0.00231	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—AKT3—epilepsy syndrome	3.29e-05	0.00229	CbGpPWpGaD
Gadobenate Dimeglumine—Dyspepsia—Gabapentin—epilepsy syndrome	3.28e-05	0.000136	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Topiramate—epilepsy syndrome	3.27e-05	0.000136	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Topiramate—epilepsy syndrome	3.27e-05	0.000136	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Topiramate—epilepsy syndrome	3.27e-05	0.000136	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Topiramate—epilepsy syndrome	3.26e-05	0.000135	CcSEcCtD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	3.26e-05	0.00227	CbGpPWpGaD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	3.25e-05	0.000135	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Topiramate—epilepsy syndrome	3.23e-05	0.000134	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Pregabalin—epilepsy syndrome	3.23e-05	0.000134	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Valproic Acid—epilepsy syndrome	3.23e-05	0.000134	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	3.22e-05	0.000133	CcSEcCtD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—PTGS2—epilepsy syndrome	3.22e-05	0.00224	CbGpPWpGaD
Gadobenate Dimeglumine—Fatigue—Gabapentin—epilepsy syndrome	3.21e-05	0.000133	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Pregabalin—epilepsy syndrome	3.21e-05	0.000133	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Pregabalin—epilepsy syndrome	3.21e-05	0.000133	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Topiramate—epilepsy syndrome	3.2e-05	0.000133	CcSEcCtD
Gadobenate Dimeglumine—Pain—Gabapentin—epilepsy syndrome	3.19e-05	0.000132	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Gabapentin—epilepsy syndrome	3.19e-05	0.000132	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Valproic Acid—epilepsy syndrome	3.18e-05	0.000132	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Topiramate—epilepsy syndrome	3.16e-05	0.000131	CcSEcCtD
Gadobenate Dimeglumine—ALB—Hemostasis—FLNA—epilepsy syndrome	3.15e-05	0.0022	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—SLC-mediated transmembrane transport—SLC2A1—epilepsy syndrome	3.13e-05	0.00218	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	3.12e-05	0.00218	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	3.12e-05	0.00218	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	3.12e-05	0.00218	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	3.12e-05	0.00218	CbGpPWpGaD
Gadobenate Dimeglumine—Infection—Topiramate—epilepsy syndrome	3.12e-05	0.000129	CcSEcCtD
Gadobenate Dimeglumine—Shock—Topiramate—epilepsy syndrome	3.09e-05	0.000128	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Valproic Acid—epilepsy syndrome	3.08e-05	0.000127	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Topiramate—epilepsy syndrome	3.08e-05	0.000127	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Gabapentin—epilepsy syndrome	3.07e-05	0.000127	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Topiramate—epilepsy syndrome	3.06e-05	0.000127	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Gabapentin—epilepsy syndrome	3.05e-05	0.000126	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Topiramate—epilepsy syndrome	3.05e-05	0.000126	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Topiramate—epilepsy syndrome	3.03e-05	0.000126	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—CDC42—epilepsy syndrome	3e-05	0.00209	CbGpPWpGaD
Gadobenate Dimeglumine—Hypersensitivity—Pregabalin—epilepsy syndrome	3e-05	0.000124	CcSEcCtD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—IL1B—epilepsy syndrome	2.99e-05	0.00209	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—KCNMA1—epilepsy syndrome	2.99e-05	0.00208	CbGpPWpGaD
Gadobenate Dimeglumine—Dizziness—Valproic Acid—epilepsy syndrome	2.97e-05	0.000123	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Gabapentin—epilepsy syndrome	2.96e-05	0.000123	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	2.96e-05	0.00206	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—SLC8A1—epilepsy syndrome	2.95e-05	0.00206	CbGpPWpGaD
Gadobenate Dimeglumine—Body temperature increased—Gabapentin—epilepsy syndrome	2.95e-05	0.000122	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Gabapentin—epilepsy syndrome	2.95e-05	0.000122	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Topiramate—epilepsy syndrome	2.93e-05	0.000121	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Pregabalin—epilepsy syndrome	2.92e-05	0.000121	CcSEcCtD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	2.9e-05	0.00202	CbGpPWpGaD
Gadobenate Dimeglumine—Pruritus—Pregabalin—epilepsy syndrome	2.88e-05	0.000119	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Valproic Acid—epilepsy syndrome	2.86e-05	0.000118	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	2.86e-05	0.000118	CcSEcCtD
Gadobenate Dimeglumine—Rash—Valproic Acid—epilepsy syndrome	2.84e-05	0.000117	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Valproic Acid—epilepsy syndrome	2.83e-05	0.000117	CcSEcCtD
Gadobenate Dimeglumine—Headache—Valproic Acid—epilepsy syndrome	2.82e-05	0.000117	CcSEcCtD
Gadobenate Dimeglumine—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—epilepsy syndrome	2.82e-05	0.00196	CbGpPWpGaD
Gadobenate Dimeglumine—Paraesthesia—Topiramate—epilepsy syndrome	2.82e-05	0.000117	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Topiramate—epilepsy syndrome	2.8e-05	0.000116	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Topiramate—epilepsy syndrome	2.79e-05	0.000116	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism—PDXK—epilepsy syndrome	2.79e-05	0.00194	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—CERS1—epilepsy syndrome	2.79e-05	0.00194	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—L2HGDH—epilepsy syndrome	2.79e-05	0.00194	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—GLUD1—epilepsy syndrome	2.79e-05	0.00194	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—ADK—epilepsy syndrome	2.79e-05	0.00194	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—FAR1—epilepsy syndrome	2.79e-05	0.00194	CbGpPWpGaD
Gadobenate Dimeglumine—Diarrhoea—Pregabalin—epilepsy syndrome	2.78e-05	0.000115	CcSEcCtD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	2.77e-05	0.00193	CbGpPWpGaD
Gadobenate Dimeglumine—Dyspepsia—Topiramate—epilepsy syndrome	2.76e-05	0.000114	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Gabapentin—epilepsy syndrome	2.75e-05	0.000114	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet degranulation—VEGFA—epilepsy syndrome	2.74e-05	0.00191	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Folate Metabolism—TNF—epilepsy syndrome	2.74e-05	0.00191	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	2.73e-05	0.0019	CbGpPWpGaD
Gadobenate Dimeglumine—Gastrointestinal disorder—Topiramate—epilepsy syndrome	2.71e-05	0.000112	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Topiramate—epilepsy syndrome	2.7e-05	0.000112	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Pregabalin—epilepsy syndrome	2.69e-05	0.000111	CcSEcCtD
Gadobenate Dimeglumine—Pain—Topiramate—epilepsy syndrome	2.68e-05	0.000111	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Topiramate—epilepsy syndrome	2.68e-05	0.000111	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Gabapentin—epilepsy syndrome	2.68e-05	0.000111	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—FYN—epilepsy syndrome	2.67e-05	0.00186	CbGpPWpGaD
Gadobenate Dimeglumine—Nausea—Valproic Acid—epilepsy syndrome	2.67e-05	0.000111	CcSEcCtD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	2.66e-05	0.00185	CbGpPWpGaD
Gadobenate Dimeglumine—Pruritus—Gabapentin—epilepsy syndrome	2.64e-05	0.000109	CcSEcCtD
Gadobenate Dimeglumine—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—epilepsy syndrome	2.61e-05	0.00182	CbGpPWpGaD
Gadobenate Dimeglumine—Vomiting—Pregabalin—epilepsy syndrome	2.59e-05	0.000107	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Topiramate—epilepsy syndrome	2.58e-05	0.000107	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—YWHAZ—epilepsy syndrome	2.57e-05	0.00179	CbGpPWpGaD
Gadobenate Dimeglumine—Gastrointestinal pain—Topiramate—epilepsy syndrome	2.57e-05	0.000106	CcSEcCtD
Gadobenate Dimeglumine—Rash—Pregabalin—epilepsy syndrome	2.56e-05	0.000106	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Pregabalin—epilepsy syndrome	2.56e-05	0.000106	CcSEcCtD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	2.56e-05	0.00178	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—SLC-mediated transmembrane transport—AVP—epilepsy syndrome	2.55e-05	0.00178	CbGpPWpGaD
Gadobenate Dimeglumine—Diarrhoea—Gabapentin—epilepsy syndrome	2.55e-05	0.000106	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism—PNPO—epilepsy syndrome	2.55e-05	0.00177	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—EPM2A—epilepsy syndrome	2.55e-05	0.00177	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—NHLRC1—epilepsy syndrome	2.55e-05	0.00177	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—GAMT—epilepsy syndrome	2.55e-05	0.00177	CbGpPWpGaD
Gadobenate Dimeglumine—Headache—Pregabalin—epilepsy syndrome	2.55e-05	0.000106	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Topiramate—epilepsy syndrome	2.49e-05	0.000103	CcSEcCtD
Gadobenate Dimeglumine—ALB—Hemostasis—PPIA—epilepsy syndrome	2.48e-05	0.00173	CbGpPWpGaD
Gadobenate Dimeglumine—Abdominal pain—Topiramate—epilepsy syndrome	2.48e-05	0.000103	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Topiramate—epilepsy syndrome	2.48e-05	0.000103	CcSEcCtD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	2.47e-05	0.00172	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	2.47e-05	0.00172	CbGpPWpGaD
Gadobenate Dimeglumine—Dizziness—Gabapentin—epilepsy syndrome	2.47e-05	0.000102	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Pregabalin—epilepsy syndrome	2.42e-05	0.0001	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Gabapentin—epilepsy syndrome	2.37e-05	9.82e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism—CA4—epilepsy syndrome	2.37e-05	0.00165	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—QDPR—epilepsy syndrome	2.37e-05	0.00165	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	2.37e-05	0.00165	CbGpPWpGaD
Gadobenate Dimeglumine—Rash—Gabapentin—epilepsy syndrome	2.35e-05	9.74e-05	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Gabapentin—epilepsy syndrome	2.35e-05	9.73e-05	CcSEcCtD
Gadobenate Dimeglumine—Headache—Gabapentin—epilepsy syndrome	2.34e-05	9.67e-05	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Topiramate—epilepsy syndrome	2.31e-05	9.57e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Hemostasis—ATP2A2—epilepsy syndrome	2.27e-05	0.00158	CbGpPWpGaD
Gadobenate Dimeglumine—Asthenia—Topiramate—epilepsy syndrome	2.25e-05	9.32e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism—COX3—epilepsy syndrome	2.23e-05	0.00155	CbGpPWpGaD
Gadobenate Dimeglumine—Pruritus—Topiramate—epilepsy syndrome	2.22e-05	9.19e-05	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Gabapentin—epilepsy syndrome	2.21e-05	9.17e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	2.2e-05	0.00153	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—ITGA2—epilepsy syndrome	2.2e-05	0.00153	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—TNF—epilepsy syndrome	2.17e-05	0.00151	CbGpPWpGaD
Gadobenate Dimeglumine—Diarrhoea—Topiramate—epilepsy syndrome	2.15e-05	8.89e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—PRKCB—epilepsy syndrome	2.12e-05	0.00148	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—KCNB1—epilepsy syndrome	2.11e-05	0.00147	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—SLCO1A2—epilepsy syndrome	2.11e-05	0.00147	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PFKL—epilepsy syndrome	2.11e-05	0.00147	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—CACNA2D2—epilepsy syndrome	2.11e-05	0.00147	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—SLC6A8—epilepsy syndrome	2.11e-05	0.00147	CbGpPWpGaD
Gadobenate Dimeglumine—Dizziness—Topiramate—epilepsy syndrome	2.07e-05	8.59e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	2.06e-05	0.00144	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	2.05e-05	0.00143	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	2.01e-05	0.0014	CbGpPWpGaD
Gadobenate Dimeglumine—Vomiting—Topiramate—epilepsy syndrome	1.99e-05	8.26e-05	CcSEcCtD
Gadobenate Dimeglumine—Rash—Topiramate—epilepsy syndrome	1.98e-05	8.19e-05	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Topiramate—epilepsy syndrome	1.98e-05	8.18e-05	CcSEcCtD
Gadobenate Dimeglumine—Headache—Topiramate—epilepsy syndrome	1.97e-05	8.14e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	1.96e-05	0.00137	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—ADRA2A—epilepsy syndrome	1.93e-05	0.00135	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—NEU1—epilepsy syndrome	1.93e-05	0.00135	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—ATIC—epilepsy syndrome	1.93e-05	0.00135	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—UPB1—epilepsy syndrome	1.93e-05	0.00135	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—PLAT—epilepsy syndrome	1.93e-05	0.00134	CbGpPWpGaD
Gadobenate Dimeglumine—Nausea—Topiramate—epilepsy syndrome	1.86e-05	7.72e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism—HSD17B4—epilepsy syndrome	1.86e-05	0.00129	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—NOS1—epilepsy syndrome	1.81e-05	0.00126	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PPP1R3C—epilepsy syndrome	1.79e-05	0.00125	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—GBE1—epilepsy syndrome	1.79e-05	0.00125	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.75e-05	0.00122	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—AKT3—epilepsy syndrome	1.7e-05	0.00118	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—ASAH1—epilepsy syndrome	1.69e-05	0.00118	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—PLAUR—epilepsy syndrome	1.68e-05	0.00117	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	1.67e-05	0.00116	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—STXBP1—epilepsy syndrome	1.64e-05	0.00114	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—NT5E—epilepsy syndrome	1.6e-05	0.00111	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—ALAD—epilepsy syndrome	1.6e-05	0.00111	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	1.59e-05	0.00111	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—CDC42—epilepsy syndrome	1.55e-05	0.00108	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—CACNA1A—epilepsy syndrome	1.53e-05	0.00106	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—ALDH7A1—epilepsy syndrome	1.53e-05	0.00106	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—ST3GAL3—epilepsy syndrome	1.49e-05	0.00104	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—ADSL—epilepsy syndrome	1.46e-05	0.00102	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—GLUL—epilepsy syndrome	1.43e-05	0.001	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—CACNA1D—epilepsy syndrome	1.41e-05	0.000981	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—FYN—epilepsy syndrome	1.38e-05	0.00096	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—YWHAZ—epilepsy syndrome	1.32e-05	0.000923	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—TXNRD1—epilepsy syndrome	1.32e-05	0.000918	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.31e-05	0.000912	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.3e-05	0.000904	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—AQP1—epilepsy syndrome	1.28e-05	0.000891	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	1.26e-05	0.000875	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—SRC—epilepsy syndrome	1.25e-05	0.000868	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.23e-05	0.000856	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—VEGFA—epilepsy syndrome	1.21e-05	0.000846	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—PLAU—epilepsy syndrome	1.18e-05	0.000819	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—KCNJ11—epilepsy syndrome	1.16e-05	0.000806	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—CHRM3—epilepsy syndrome	1.16e-05	0.000806	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—PRKCB—epilepsy syndrome	1.09e-05	0.000762	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—NOS2—epilepsy syndrome	1.08e-05	0.000753	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.08e-05	0.00075	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.06e-05	0.000735	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—ABCG2—epilepsy syndrome	9.43e-06	0.000657	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—CYP2C19—epilepsy syndrome	9.19e-06	0.00064	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—CYP11A1—epilepsy syndrome	9.13e-06	0.000636	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	9.07e-06	0.000632	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—CYP2D6—epilepsy syndrome	8.24e-06	0.000574	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—ADRA2A—epilepsy syndrome	7.85e-06	0.000547	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—BCHE—epilepsy syndrome	7.81e-06	0.000544	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	7.74e-06	0.00054	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—SLC2A1—epilepsy syndrome	7.45e-06	0.000519	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PLCB1—epilepsy syndrome	7.37e-06	0.000514	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—TH—epilepsy syndrome	7.35e-06	0.000512	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	7.23e-06	0.000504	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—SRC—epilepsy syndrome	6.42e-06	0.000448	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—VEGFA—epilepsy syndrome	6.26e-06	0.000436	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—HMOX1—epilepsy syndrome	6.13e-06	0.000427	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—CAT—epilepsy syndrome	6.05e-06	0.000421	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—ABCB1—epilepsy syndrome	5.88e-06	0.00041	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—GPX1—epilepsy syndrome	5.47e-06	0.000381	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—AGT—epilepsy syndrome	4.8e-06	0.000334	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—APOE—epilepsy syndrome	4.7e-06	0.000327	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—POMC—epilepsy syndrome	4.04e-06	0.000281	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—AKT1—epilepsy syndrome	3.99e-06	0.000278	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PTGS2—epilepsy syndrome	3.22e-06	0.000224	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—AKT1—epilepsy syndrome	1.62e-06	0.000113	CbGpPWpGaD
